Top compounds associated with response to BRMS1


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.056 0.1
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.047 0.1
mRNA linifanib GDSC1000 pan-cancer AAC -0.058 0.1
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.1
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC -0.061 0.1
mRNA STF-62247 GDSC1000 pan-cancer AAC 0.054 0.1
mRNA PF-543 CTRPv2 pan-cancer AAC -0.062 0.1
mRNA EKB-569 GDSC1000 pan-cancer AAC 0.054 0.1
mRNA PL-DI CTRPv2 pan-cancer AAC -0.051 0.1
mRNA CHIR-99021 GDSC1000 pan-cancer AAC 0.051 0.1
Download CSV